India's Krsna Diagnostics gains on strong Q1 results

Dr. Lal PathLabs

07/08/2024 06:03

** Shares of Krsna Diagnostics  KRSN.NS  up ~ 5% at 672.70
rupees
    ** Co on Tuesday reported 24% Y/Y surge in Q1 profit after
tax, while rev rose 22%
    ** Stk down 6.3% YTD, biggest drag among diagnostic stocks
    ** Peers Vijaya Diagnostic  VIJA.NS  up 18% YTD, Thyrocare
 THYO.NS  up ~ 21%, Metropolis Health  METP.NS  up 23%, Dr Lal
Path  DLPA.NS  up 23%
    ** KRSN, Thyrocare "strong buy" rated on average; METP, DLPA
"hold" rated, while VIJA "buy" rated - LSEG

 (Reporting by Sethuraman NR in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))